Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK573719 Monotherapy in Asthma
NCT01641692Phase 2Completed
- Sponsor
- GSK
- Start
- May 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of umeclidinium in asthma, sponsored by GSK. Started May 2012; status: completed.
02
Drugs
umeclidinium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01641692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01641692.